171260 AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem

171260
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Tabla espec. clave

      Empirical FormulaCAS #
      C₂₄H₂₅N₅O 866405-64-3

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1171260-10MG
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          Ampolla de plást. 10 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          US1171260-1MG
          Comprobando disponibilidad...
          Disponibilidad a confirmarDisponibilidad a confirmar
          En existencia 
          Suspendido
          Cantidades limitadas disponibles
          Debe confirmarse disponibilidad
            El resto: se avisará
              El resto: se avisará
              Se avisará
              Póngase en contacto con el Servicio de Atención al Cliente
              Contact Customer Service

              Ampolla de plást. 1 mg
              Recuperando precio...
              No pudo obtenerse el precio
              La cantidad mínima tiene que ser múltiplo de
              Al finalizar el pedido Más información
              Ahorró ()
               
              Solicitar precio
              US1171260-5MG
              Comprobando disponibilidad...
              Disponibilidad a confirmarDisponibilidad a confirmar
              En existencia 
              Suspendido
              Cantidades limitadas disponibles
              Debe confirmarse disponibilidad
                El resto: se avisará
                  El resto: se avisará
                  Se avisará
                  Póngase en contacto con el Servicio de Atención al Cliente
                  Contact Customer Service

                  Ampolla de plást. 5 mg
                  Recuperando precio...
                  No pudo obtenerse el precio
                  La cantidad mínima tiene que ser múltiplo de
                  Al finalizar el pedido Más información
                  Ahorró ()
                   
                  Solicitar precio
                  Description
                  OverviewA cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo. Also available as a 10 mM solution in DMSO (Cat. No. 171261).
                  Catalogue Number171260
                  Brand Family Calbiochem®
                  Synonyms6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, AMPK Inhibitor I, BMP Inhibitor I
                  References
                  ReferencesHao, J., et al. 2010. ACS Chem.Biol. 5, 245.
                  Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
                  Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
                  Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
                  Inoki, K., et al. 2003. Cell 115, 577.
                  Fryer, L.G., 2002. FEBS Lett. 531, 189.
                  Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.
                  Product Information
                  CAS number866405-64-3
                  ATP CompetitiveY
                  FormLight yellow solid
                  Hill FormulaC₂₄H₂₅N₅O
                  Chemical formulaC₂₄H₂₅N₅O
                  ReversibleY
                  Structure formula ImageStructure formula Image
                  Applications
                  Biological Information
                  Primary TargetAMPK
                  Primary Target IC<sub>50</sub>25.1, 148, and 234.6 nM, against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity, respectively
                  Primary Target K<sub>i</sub>EC100 = 2.5 µM against BMP pathway-dependent dorsoventral development; EC50 = 5 µM against VEGF signaling-dependent intersomitic vessel formation in zebrafish embryo in vivo
                  Purity≥95% by HPLC
                  Physicochemical Information
                  Cell permeableY
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  Safety Information
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
                  Toxicity Standard Handling
                  Storage +2°C to +8°C
                  Protect from Light Protect from light
                  Do not freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
                  Packaging Information
                  Packaged under inert gas Packaged under inert gas
                  Transport Information
                  Supplemental Information
                  Specifications

                  Documentation

                  Ficha datos de seguridad (MSDS)

                  Título

                  Ficha técnica de seguridad del material (MSDS) 

                  Certificados de análisis

                  CargoNúmero de lote
                  171260

                  Referencias bibliográficas

                  Visión general referencias
                  Hao, J., et al. 2010. ACS Chem.Biol. 5, 245.
                  Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
                  Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
                  Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
                  Inoki, K., et al. 2003. Cell 115, 577.
                  Fryer, L.G., 2002. FEBS Lett. 531, 189.
                  Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.
                  Ficha técnica

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision22-March-2012 JSW
                  Synonyms6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, AMPK Inhibitor I, BMP Inhibitor I
                  DescriptionA cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo. Also available as a 10 mM solution in DMSO (Cat. No. 171261).
                  FormLight yellow solid
                  Intert gas (Yes/No) Packaged under inert gas
                  CAS number866405-64-3
                  Chemical formulaC₂₄H₂₅N₅O
                  Structure formulaStructure formula
                  Purity≥95% by HPLC
                  SolubilityDMSO (4 mg/ml), 2% HCl (10 mg/ml), 2% Acetic Acid (10 mg/ml), or Methanol (3 mg/ml)
                  Storage +2°C to +8°C
                  Protect from light
                  Do Not Freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
                  Toxicity Standard Handling
                  ReferencesHao, J., et al. 2010. ACS Chem.Biol. 5, 245.
                  Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
                  Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
                  Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
                  Inoki, K., et al. 2003. Cell 115, 577.
                  Fryer, L.G., 2002. FEBS Lett. 531, 189.
                  Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.